Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Acute respiratory distress syndrome in leptospirosis.

Vandroux D, Chanareille P, Delmas B, Gaüzère BA, Allou N, Raffray L, Jaffar-Bandjee MC, Martinet O, Ferdynus C, Jabot J.

J Crit Care. 2019 Jun;51:165-169. doi: 10.1016/j.jcrc.2019.02.018. Epub 2019 Feb 18.

PMID:
30831550
2.

ICTV virus taxonomy profile: Picobirnaviridae.

Delmas B, Attoui H, Ghosh S, Malik YS, Mundt E, Vakharia VN, Ictv Report Consortium.

J Gen Virol. 2019 Feb;100(2):133-134. doi: 10.1099/jgv.0.001186. Epub 2018 Nov 28.

PMID:
30484763
3.

ICTV virus taxonomy profile: Birnaviridae.

Delmas B, Attoui H, Ghosh S, Malik YS, Mundt E, Vakharia VN, Ictv Report Consortium.

J Gen Virol. 2019 Jan;100(1):5-6. doi: 10.1099/jgv.0.001185. Epub 2018 Nov 28.

PMID:
30484762
4.

Predictors of red blood cell transfusion and its association with prognosis in patients undergoing extracorporeal membrane oxygenation.

Lo Pinto H, Allyn J, Persichini R, Bouchet B, Brochier G, Martinet O, Brulliard C, Valance D, Delmas B, Braunberger E, Dangers L, Allou N.

Int J Artif Organs. 2018 Oct;41(10):644-652. doi: 10.1177/0391398818785132. Epub 2018 Jul 12.

PMID:
29998775
5.

Cannula-Related Infection in Patients Supported by Peripheral ECMO: Clinical and Microbiological Characteristics.

Allou N, Lo Pinto H, Persichini R, Bouchet B, Braunberger E, Lugagne N, Belmonte O, Martinet O, Delmas B, Dangers L, Allyn J.

ASAIO J. 2019 Feb;65(2):180-186. doi: 10.1097/MAT.0000000000000771.

PMID:
29517513
6.

Extracorporeal membrane oxygenation for cardiogenic shock due to alcoholic cardiomyopathy: a long-term follow-up of 4 cases.

Valance D, Bouchet B, Brulliard C, Delmas B, Puech B, Braunberger E, Allou N, Allyn J.

Interact Cardiovasc Thorac Surg. 2018 Apr 1;26(4):703-705. doi: 10.1093/icvts/ivx388.

PMID:
29281011
7.

Leptospirosis in ICU: A Retrospective Study of 134 Consecutive Admissions.

Delmas B, Jabot J, Chanareille P, Ferdynus C, Allyn J, Allou N, Raffray L, Gaüzere BA, Martinet O, Vandroux D.

Crit Care Med. 2018 Jan;46(1):93-99. doi: 10.1097/CCM.0000000000002825.

PMID:
29116996
8.

Host Response Comparison of H1N1- and H5N1-Infected Mice Identifies Two Potential Death Mechanisms.

Leymarie O, Meyer L, Hervé PL, Da Costa B, Delmas B, Chevalier C, Le Goffic R.

Int J Mol Sci. 2017 Jul 27;18(8). pii: E1631. doi: 10.3390/ijms18081631.

9.

Influenza virus protein PB1-F2 interacts with CALCOCO2 (NDP52) to modulate innate immune response.

Leymarie O, Meyer L, Tafforeau L, Lotteau V, Costa BD, Delmas B, Chevalier C, Le Goffic R.

J Gen Virol. 2017 Jun;98(6):1196-1208. doi: 10.1099/jgv.0.000782. Epub 2017 Jun 14.

PMID:
28613140
10.

Transcriptomic profiling of a chicken lung epithelial cell line (CLEC213) reveals a mitochondrial respiratory chain activity boost during influenza virus infection.

Meyer L, Leymarie O, Chevalier C, Esnault E, Moroldo M, Da Costa B, Georgeault S, Roingeard P, Delmas B, Quéré P, Le Goffic R.

PLoS One. 2017 Apr 25;12(4):e0176355. doi: 10.1371/journal.pone.0176355. eCollection 2017.

11.

[Severe pulmonary embolism revealed by status epilepticus].

Allou N, Coolen-Allou N, Delmas B, Cordier C, Allyn J.

Rev Pneumol Clin. 2016 Dec;72(6):377-379. doi: 10.1016/j.pneumo.2016.10.001. Epub 2016 Oct 31. French.

PMID:
27810245
12.

The Influenza Virus Protein PB1-F2 Increases Viral Pathogenesis through Neutrophil Recruitment and NK Cells Inhibition.

Vidy A, Maisonnasse P, Da Costa B, Delmas B, Chevalier C, Le Goffic R.

PLoS One. 2016 Oct 31;11(10):e0165361. doi: 10.1371/journal.pone.0165361. eCollection 2016.

13.

Assessment of the National French recommendations regarding the dosing regimen of 8mg/kg of gentamicin in patients hospitalised in intensive care units.

Allou N, Allyn J, Levy Y, Bouteau A, Caujolle M, Delmas B, Valance D, Brulliard C, Martinet O, Vandroux D, Montravers P, Augustin P.

Anaesth Crit Care Pain Med. 2016 Oct;35(5):331-335. doi: 10.1016/j.accpm.2015.12.012. Epub 2016 Apr 28.

PMID:
27133236
14.

[Influenza A/H1N1 virus infections associated with bacterial infections complicated by extensive compartment syndrome].

Allou N, Coolen-Allou N, Delmas B, Jabot J, Valance D, Galliot R, Allyn J.

Med Mal Infect. 2016 Oct;46(7):390-392. doi: 10.1016/j.medmal.2016.02.004. Epub 2016 Mar 30. French. No abstract available.

PMID:
27039065
15.

Synchrotron Infrared and Deep UV Fluorescent Microspectroscopy Study of PB1-F2 β-Aggregated Structures in Influenza A Virus-infected Cells.

Chevalier C, Le Goffic R, Jamme F, Leymarie O, Réfrégiers M, Delmas B.

J Biol Chem. 2016 Apr 22;291(17):9060-72. doi: 10.1074/jbc.M115.710533. Epub 2016 Feb 19.

16.

Codon Deletions in the Influenza A Virus PA Gene Generate Temperature-Sensitive Viruses.

Meyer L, Sausset A, Sedano L, Da Costa B, Le Goffic R, Delmas B.

J Virol. 2016 Jan 20;90(7):3684-93. doi: 10.1128/JVI.03101-15.

17.

Amyloid Assemblies of Influenza A Virus PB1-F2 Protein Damage Membrane and Induce Cytotoxicity.

Vidic J, Richard CA, Péchoux C, Da Costa B, Bertho N, Mazerat S, Delmas B, Chevalier C.

J Biol Chem. 2016 Jan 8;291(2):739-51. doi: 10.1074/jbc.M115.652917. Epub 2015 Nov 24.

18.

Temperature-Sensitive Mutants in the Influenza A Virus RNA Polymerase: Alterations in the PA Linker Reduce Nuclear Targeting of the PB1-PA Dimer and Result in Viral Attenuation.

Da Costa B, Sausset A, Munier S, Ghounaris A, Naffakh N, Le Goffic R, Delmas B.

J Virol. 2015 Jun;89(12):6376-90. doi: 10.1128/JVI.00589-15. Epub 2015 Apr 8.

19.

Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenza.

Monod A, Swale C, Tarus B, Tissot A, Delmas B, Ruigrok RW, Crépin T, Slama-Schwok A.

Expert Opin Drug Discov. 2015 Apr;10(4):345-71. doi: 10.1517/17460441.2015.1019859. Review.

PMID:
25792362
20.

PB1-F2 attenuates virulence of highly pathogenic avian H5N1 influenza virus in chickens.

Leymarie O, Embury-Hyatt C, Chevalier C, Jouneau L, Moroldo M, Da Costa B, Berhane Y, Delmas B, Weingartl HM, Le Goffic R.

PLoS One. 2014 Jun 24;9(6):e100679. doi: 10.1371/journal.pone.0100679. eCollection 2014.

21.

Direct electrochemical detection of PB1-F2 protein of influenza A virus in infected cells.

Miodek A, Sauriat-Dorizon H, Chevalier C, Delmas B, Vidic J, Korri-Youssoufi H.

Biosens Bioelectron. 2014 Sep 15;59:6-13. doi: 10.1016/j.bios.2014.02.037. Epub 2014 Feb 26.

PMID:
24686222
22.

Influenza virus nucleoprotein: structure, RNA binding, oligomerization and antiviral drug target.

Chenavas S, Crépin T, Delmas B, Ruigrok RW, Slama-Schwok A.

Future Microbiol. 2013 Dec;8(12):1537-45. doi: 10.2217/fmb.13.128. Review.

PMID:
24266354
24.

Selective antibacterial effects of mixed ZnMgO nanoparticles.

Vidic J, Stankic S, Haque F, Ciric D, Le Goffic R, Vidy A, Jupille J, Delmas B.

J Nanopart Res. 2013 May;15(5):1595. Epub 2013 Apr 6.

25.

Epidemiology, molecular virology and diagnostics of Schmallenberg virus, an emerging orthobunyavirus in Europe.

Doceul V, Lara E, Sailleau C, Belbis G, Richardson J, Bréard E, Viarouge C, Dominguez M, Hendrikx P, Calavas D, Desprat A, Languille J, Comtet L, Pourquier P, Eléouët JF, Delmas B, Marianneau P, Vitour D, Zientara S.

Vet Res. 2013 May 15;44:31. doi: 10.1186/1297-9716-44-31. Review.

26.

Monomeric nucleoprotein of influenza A virus.

Chenavas S, Estrozi LF, Slama-Schwok A, Delmas B, Di Primo C, Baudin F, Li X, Crépin T, Ruigrok RW.

PLoS Pathog. 2013 Mar;9(3):e1003275. doi: 10.1371/journal.ppat.1003275. Epub 2013 Mar 28.

27.

Kinetic characterization of PB1-F2-mediated immunopathology during highly pathogenic avian H5N1 influenza virus infection.

Leymarie O, Jouvion G, Hervé PL, Chevalier C, Lorin V, Lecardonnel J, Da Costa B, Delmas B, Escriou N, Le Goffic R.

PLoS One. 2013;8(3):e57894. doi: 10.1371/journal.pone.0057894. Epub 2013 Mar 1.

28.

Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus.

Lejal N, Tarus B, Bouguyon E, Chenavas S, Bertho N, Delmas B, Ruigrok RW, Di Primo C, Slama-Schwok A.

Antimicrob Agents Chemother. 2013 May;57(5):2231-42. doi: 10.1128/AAC.02335-12. Epub 2013 Mar 4.

29.

Molecular dynamics studies of the nucleoprotein of influenza A virus: role of the protein flexibility in RNA binding.

Tarus B, Chevalier C, Richard CA, Delmas B, Di Primo C, Slama-Schwok A.

PLoS One. 2012;7(1):e30038. doi: 10.1371/journal.pone.0030038. Epub 2012 Jan 17.

30.

Oligomerization paths of the nucleoprotein of influenza A virus.

Tarus B, Bakowiez O, Chenavas S, Duchemin L, Estrozi LF, Bourdieu C, Lejal N, Bernard J, Moudjou M, Chevalier C, Delmas B, Ruigrok RW, Di Primo C, Slama-Schwok A.

Biochimie. 2012 Mar;94(3):776-85. doi: 10.1016/j.biochi.2011.11.009. Epub 2011 Nov 29.

PMID:
22155087
31.

Transcriptomic analysis of host immune and cell death responses associated with the influenza A virus PB1-F2 protein.

Le Goffic R, Leymarie O, Chevalier C, Rebours E, Da Costa B, Vidic J, Descamps D, Sallenave JM, Rauch M, Samson M, Delmas B.

PLoS Pathog. 2011 Aug;7(8):e1002202. doi: 10.1371/journal.ppat.1002202. Epub 2011 Aug 25.

32.

Infection with influenza virus induces IL-33 in murine lungs.

Le Goffic R, Arshad MI, Rauch M, L'Helgoualc'h A, Delmas B, Piquet-Pellorce C, Samson M.

Am J Respir Cell Mol Biol. 2011 Dec;45(6):1125-32. doi: 10.1165/rcmb.2010-0516OC. Epub 2011 Jun 3.

PMID:
21642589
33.

Picobirnaviruses encode a protein with repeats of the ExxRxNxxxE motif.

Da Costa B, Duquerroy S, Tarus B, Delmas B.

Virus Res. 2011 Jun;158(1-2):251-6. doi: 10.1016/j.virusres.2011.02.018. Epub 2011 Mar 2.

PMID:
21376090
34.

Influenza A virus protein PB1-F2 exacerbates IFN-beta expression of human respiratory epithelial cells.

Le Goffic R, Bouguyon E, Chevalier C, Vidic J, Da Costa B, Leymarie O, Bourdieu C, Decamps L, Dhorne-Pollet S, Delmas B.

J Immunol. 2010 Oct 15;185(8):4812-23. doi: 10.4049/jimmunol.0903952. Epub 2010 Sep 15.

35.

NMR structure of a viral peptide inserted in artificial membranes: a view on the early steps of the birnavirus entry process.

Galloux M, Libersou S, Alves ID, Marquant R, Salgado GF, Rezaei H, Lepault J, Delmas B, Bouaziz S, Morellet N.

J Biol Chem. 2010 Jun 18;285(25):19409-21. doi: 10.1074/jbc.M109.076083. Epub 2010 Apr 9.

36.

PB1-F2 influenza A virus protein adopts a beta-sheet conformation and forms amyloid fibers in membrane environments.

Chevalier C, Al Bazzal A, Vidic J, Février V, Bourdieu C, Bouguyon E, Le Goffic R, Vautherot JF, Bernard J, Moudjou M, Noinville S, Chich JF, Da Costa B, Rezaei H, Delmas B.

J Biol Chem. 2010 Apr 23;285(17):13233-43. doi: 10.1074/jbc.M109.067710. Epub 2010 Feb 19.

37.

Crystal structure of an Aquabirnavirus particle: insights into antigenic diversity and virulence determinism.

Coulibaly F, Chevalier C, Delmas B, Rey FA.

J Virol. 2010 Feb;84(4):1792-9. doi: 10.1128/JVI.01536-09. Epub 2009 Dec 9.

38.

The picobirnavirus crystal structure provides functional insights into virion assembly and cell entry.

Duquerroy S, Da Costa B, Henry C, Vigouroux A, Libersou S, Lepault J, Navaza J, Delmas B, Rey FA.

EMBO J. 2009 Jun 3;28(11):1655-65. doi: 10.1038/emboj.2009.109. Epub 2009 Apr 30.

39.

Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigenic site.

Rémond M, Da Costa B, Riffault S, Parida S, Breard E, Lebreton F, Zientara S, Delmas B.

Vaccine. 2009 Jan 1;27(1):93-8. doi: 10.1016/j.vaccine.2008.10.036. Epub 2008 Nov 5.

PMID:
18983883
40.

Replication and packaging of an infectious bursal disease virus segment A-derived minigenome.

Ben Abdeljelil N, Delmas B, Mardassi H.

Virus Res. 2008 Sep;136(1-2):146-51. doi: 10.1016/j.virusres.2008.05.002. Epub 2008 Jun 11.

PMID:
18562033
41.

Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin.

LeBouder F, Morello E, Rimmelzwaan GF, Bosse F, Péchoux C, Delmas B, Riteau B.

J Virol. 2008 Jul;82(14):6820-8. doi: 10.1128/JVI.00246-08. Epub 2008 Apr 30.

42.

Genome and polypeptides characterization of Tellina virus 1 reveals a fifth genetic cluster in the Birnaviridae family.

Nobiron I, Galloux M, Henry C, Torhy C, Boudinot P, Lejal N, Da Costa B, Delmas B.

Virology. 2008 Feb 20;371(2):350-61. Epub 2007 Oct 31.

43.

Molecular and structural bases for the antigenicity of VP2 of infectious bursal disease virus.

Letzel T, Coulibaly F, Rey FA, Delmas B, Jagt E, van Loon AA, Mundt E.

J Virol. 2007 Dec;81(23):12827-35. Epub 2007 Sep 19.

44.
45.

Infectious bursal disease virus, a non-enveloped virus, possesses a capsid-associated peptide that deforms and perforates biological membranes.

Galloux M, Libersou S, Morellet N, Bouaziz S, Da Costa B, Ouldali M, Lepault J, Delmas B.

J Biol Chem. 2007 Jul 13;282(28):20774-84. Epub 2007 May 8.

46.

Purification, crystallization and preliminary X-ray analysis of truncated and mutant forms of VP4 protease from infectious pancreatic necrosis virus.

Lee J, Feldman AR, Chiu E, Chan C, Kim YN, Delmas B, Paetzel M.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2006 Dec 1;62(Pt 12):1235-8. Epub 2006 Nov 30.

47.

Crystal structure of a novel viral protease with a serine/lysine catalytic dyad mechanism.

Feldman AR, Lee J, Delmas B, Paetzel M.

J Mol Biol. 2006 May 19;358(5):1378-89. Epub 2006 Mar 6.

PMID:
16584747
48.

Expression, purification and crystallization of a birnavirus-encoded protease, VP4, from blotched snakehead virus (BSNV).

Lee J, Feldman AR, Delmas B, Paetzel M.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2006 Apr 1;62(Pt 4):353-6. Epub 2006 Mar 10.

49.

Structural peptides of a nonenveloped virus are involved in assembly and membrane translocation.

Chevalier C, Galloux M, Pous J, Henry C, Denis J, Da Costa B, Navaza J, Lepault J, Delmas B.

J Virol. 2005 Oct;79(19):12253-63.

50.

Structure of birnavirus-like particles determined by combined electron cryomicroscopy and X-ray crystallography.

Pous J, Chevalier C, Ouldali M, Navaza J, Delmas B, Lepault J.

J Gen Virol. 2005 Aug;86(Pt 8):2339-46.

PMID:
16033982

Supplemental Content

Loading ...
Support Center